SG11201910176PA - Polymer coatings for brachytherapy devices - Google Patents

Polymer coatings for brachytherapy devices

Info

Publication number
SG11201910176PA
SG11201910176PA SG11201910176PA SG11201910176PA SG 11201910176P A SG11201910176P A SG 11201910176PA SG 11201910176P A SG11201910176P A SG 11201910176PA SG 11201910176P A SG11201910176P A SG 11201910176PA
Authority
SG
Singapore
Prior art keywords
international
street
tel aviv
pct
radionuclide
Prior art date
Application number
Inventor
Itzhak Kelson
Yona Keisari
Michael Schmidt
Avia Berkowitz
Original Assignee
Alpha Tau Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Tau Medical Ltd filed Critical Alpha Tau Medical Ltd
Publication of SG11201910176PA publication Critical patent/SG11201910176PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/06Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A61K51/1289Devices or containers for impregnation, for emanation, e.g. bottles or jars for radioactive water for use in radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069Devices for implanting pellets, e.g. markers or solid medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007Arrangements or means for the introduction of sources into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1027Interstitial radiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00Radioactive sources
    • G21G4/04Radioactive sources other than neutron sources
    • G21G4/06Radioactive sources other than neutron sources characterised by constructional features
    • G21G4/08Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/02Methods for coating medical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/08Coatings comprising two or more layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019Sources therefor
    • A61N2005/1025Wires
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/18Processes for applying liquids or other fluent materials performed by dipping
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D7/00Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
    • B05D7/50Multilayers
    • B05D7/52Two layers
    • B05D7/54No clear coat specified
    • B05D7/548No curing step for the last layer
    • B05D7/5483No curing step for any layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Laminated Bodies (AREA)

Abstract

TO 22 FIG. 1 W O 20 18/ 207 105 Al (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 15 November 2018 (15.11.2018) WIPO I PCT IiiimmomiolollmonolooloionmoionomovoimIE (10) International Publication Number WO 2018/207105 Al (51) International Patent Classification: A61N 5/10 (2006.01) C23C 14/06 (2006.01) A61K 51/12 (2006.01) C23C 14/48 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/IB2018/053213 (22) International Filing Date: 09 May 2018 (09.05.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/504,800 11 May 2017 (11.05.2017) US (71) Applicant: ALPHA TAU MEDICAL LTD. [IL/IL]; School of Physics, Tel Aviv University, P.O. Box 39040, 6997801 Tel Aviv (IL). (72) Inventors: KELSON, Itzhak; 94 Dizengoff Street, 6439606 Tel Aviv (IL). KEISARI, Yona; 8 Hagaon Eliyahu Street, 5236477 Ramat Gan (IL). SCHMIDT, Michael; 7 Eucalyptus Street, 4453507 Kfar Saba (IL). BERKOWITZ, Avia; 34/8 Hasida Street, 7169334 Modiin (IL). MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) Agent: D. KLIGLER I. P. SERVICES LTD.; P. O. Box 57651, 61576 Tel Aviv (IL). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (54) Title: POLYMER COATINGS FOR BRACHYTHERAPY DEVICES (57) : Described embodiments include an apparatus (20, 21), which includes a support (22), including an outer surface (24) and config- ured for insertion into a body of a subject. The apparatus further includes multiple atoms (26) of a radionuclide, which radioactively decays to pro- duce a daughter radionuclide, coupled to the outer surface, and a layer (28, 33) of a polymer, which is permeable to the daughter radionuclide, that covers the atoms. Other embodiments are also described.
SG11201910176P 2017-05-11 2018-05-09 Polymer coatings for brachytherapy devices SG11201910176PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762504800P 2017-05-11 2017-05-11
PCT/IB2018/053213 WO2018207105A1 (en) 2017-05-11 2018-05-09 Polymer coatings for brachytherapy devices

Publications (1)

Publication Number Publication Date
SG11201910176PA true SG11201910176PA (en) 2019-11-28

Family

ID=64104434

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201910176P SG11201910176PA (en) 2017-05-11 2018-05-09 Polymer coatings for brachytherapy devices

Country Status (12)

Country Link
US (2) US11529432B2 (en)
EP (1) EP3621692A4 (en)
JP (2) JP7232489B2 (en)
KR (1) KR102560243B1 (en)
CN (1) CN110603076A (en)
AU (1) AU2018265386B2 (en)
CA (1) CA3059534A1 (en)
MX (1) MX2019013346A (en)
RU (1) RU2763750C2 (en)
SG (1) SG11201910176PA (en)
WO (1) WO2018207105A1 (en)
ZA (1) ZA201906581B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9821174B1 (en) 2015-02-06 2017-11-21 Gammatile Llc Radioactive implant planning system and placement guide system
US10888710B1 (en) 2016-11-29 2021-01-12 Gt Medical Technologies, Inc. Transparent loading apparatus
JP2021519126A (en) 2018-04-02 2021-08-10 アルファ タウ メディカル リミテッド Controlled release of radionuclides
AU2021400142A1 (en) 2020-12-16 2023-06-22 Alpha Tau Medical Ltd. Diffusing alpha-emitters radiation therapy with enhanced beta treatment
US11964168B2 (en) 2021-06-10 2024-04-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for prostate cancer
US20220395702A1 (en) 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for glioblastoma
US20220395701A1 (en) 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for pancreatic cancer
US20220395703A1 (en) 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Activity levels for diffusing alpha-emitter radiation therapy
CN113908346B (en) * 2021-11-12 2023-03-07 上海交通大学 Radioactive lumen stent and preparation method thereof
US20230335315A1 (en) * 2022-04-14 2023-10-19 Zense-Life Inc. Coating a working wire for a continuous biological sensor

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1810528A1 (en) 1968-11-23 1970-06-04 Messerschmitt Boelkow Blohm Radionuclide generator
US3811426A (en) 1973-05-21 1974-05-21 Atomic Energy Commission Method and apparatus for the in-vessel radiation treatment of blood
US4107283A (en) 1976-07-19 1978-08-15 New England Nuclear Corporation Tracer for circulation determinations
DE3241589A1 (en) 1982-11-10 1984-05-17 Pfaudler-Werke Ag, 6830 Schwetzingen IMPLANTS AND METHOD FOR THE PRODUCTION THEREOF
US4697575A (en) 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4976680A (en) 1988-10-07 1990-12-11 Hayman Michael H Apparatus for in situ radiotherapy
US6099457A (en) 1990-08-13 2000-08-08 Endotech, Inc. Endocurietherapy
US5342283A (en) 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
US5531662A (en) 1990-12-17 1996-07-02 Microwave Medical Systems, Inc. Dual mode microwave/ionizing probe
JP3406661B2 (en) 1993-12-06 2003-05-12 日本メジフィジックス株式会社 Syringe barrel sheath
RU2089143C1 (en) 1994-03-02 1997-09-10 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Method for brachytherapy of intraocular tumors
US6589502B1 (en) * 1995-11-27 2003-07-08 International Brachytherapy S.A. Radioisotope dispersed in a matrix for brachytherapy
US5713828A (en) 1995-11-27 1998-02-03 International Brachytherapy S.A Hollow-tube brachytherapy device
CA2248076A1 (en) 1996-03-11 1997-09-18 Richard D. Leavitt Polymeric delivery of radionuclides and radiopharmaceuticals
DE19724230C1 (en) 1997-04-30 1998-11-26 Schering Ag Applying radioactive coating to stent that has been treated with adhesion promoter
WO1999002194A1 (en) 1997-07-11 1999-01-21 Innerdyne, Inc. Methods and systems for preparing and sealing radiation delivery structures
US6254552B1 (en) * 1997-10-03 2001-07-03 E.I. Du Pont De Nemours And Company Intra-coronary radiation devices containing Ce-144 or Ru-106
US6419621B1 (en) 1997-10-24 2002-07-16 Radiomed Corporation Coiled brachytherapy device
US6030333A (en) 1997-10-24 2000-02-29 Radiomed Corporation Implantable radiotherapy device
US6394945B1 (en) 1997-12-22 2002-05-28 Mds (Canada), Inc. Radioactively coated devices
US6077413A (en) 1998-02-06 2000-06-20 The Cleveland Clinic Foundation Method of making a radioactive stent
US6060036A (en) 1998-02-09 2000-05-09 Implant Sciences Corporation Radioactive seed implants
EP1054707B1 (en) 1998-02-12 2005-04-27 Robert Robertson Encapsulated low-energy brachytherapy sources
US20020131935A1 (en) 1998-04-10 2002-09-19 Fisher Darrell R. Fibrin carrier compound for treatment of disease
WO2000006243A2 (en) 1998-07-28 2000-02-10 Innerdyne, Inc. Absorbable brachytherapy and chemotherapy delivery devices and methods
US6676595B1 (en) 1998-08-24 2004-01-13 Varian Medical Systems Technologies, Inc. Radioactive medical implant and method of manufacturing
JP2002530128A (en) 1998-11-18 2002-09-17 ラジオバスキュラー、システムズ、リミテッド、ライアビリティ、カンパニー Radioactive coating solution, method and substrate
US20020077520A1 (en) 1998-11-18 2002-06-20 Jerome Segal Device and method for dilating and irradiating a vascular segment or body passageway
NO310544B1 (en) 1999-01-04 2001-07-23 Algeta As Preparation and use of radium-223 for the preparation of preparations and kits for the treatment of calcified tissue for palliation, bone cancer therapy and / or bone surface treatment
US6224536B1 (en) 1999-02-08 2001-05-01 Advanced Cardiovascular Systems Method for delivering radiation therapy to an intravascular site in a body
US6391911B1 (en) 1999-02-26 2002-05-21 Robert E. Bases Coadministration of lucanthone and radiation for treatment of cancer
US6059714A (en) 1999-03-26 2000-05-09 Implant Sciences Corporation Radioactive medical devices
US6392068B1 (en) 1999-07-07 2002-05-21 The University Of Georgia Research Foundation, Inc. Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery
AU1374601A (en) 1999-11-12 2001-05-30 Angiotech International Ag Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
US6575888B2 (en) 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device
NO312708B1 (en) 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioactive liposomes for therapy
NO313180B1 (en) 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Visiting alpha particles emitting radiopharmaceuticals
CA2320557A1 (en) 2000-09-25 2002-03-25 Michelangelo Delfino Radioactive medical implant and method of manufacturing
AU2001297657A1 (en) 2000-11-16 2002-09-12 Microspherix Llc Polymeric imagable brachytherapy seed
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US6638205B1 (en) * 2000-11-17 2003-10-28 Mds (Canada) Inc. Radioactive medical device for radiation therapy
RU2174015C1 (en) 2000-11-21 2001-09-27 Кешелава Виктор Владимирович Method for producing preparation and treating oncologic diseases
EP1232770A1 (en) * 2001-02-15 2002-08-21 AEA Technology QSA GmbH Radioactive capsule seed
EP1232769A1 (en) 2001-02-15 2002-08-21 AEA Technology QSA GmbH Capsule seed manufactured with Pd-103
WO2002078785A2 (en) 2001-04-02 2002-10-10 Radiovascular, Inc. A brachytherapy device and method of use
RU2182022C1 (en) 2001-05-24 2002-05-10 Российская медицинская академия последипломного образования МЗ РФ Method for treating oncological diseases of the thyroid gland
US6723052B2 (en) 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
US20030118649A1 (en) 2001-10-04 2003-06-26 Jinming Gao Drug delivery devices and methods
AU2003226408B2 (en) 2002-04-15 2007-06-14 Sloan-Kettering Institute For Cancer Research Combination therapy for the treatment of cancer
JP4987232B2 (en) * 2002-11-18 2012-07-25 ラットガーズ,ザ・ステート・ユニバーシティ・オブ・ニュージャージー Medical devices using new polymers
US20050222013A1 (en) 2003-01-16 2005-10-06 Georgetown University Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
US20060039858A1 (en) 2003-02-11 2006-02-23 Ekaterina Dadachova Radiolabeled antibodies and peptides for treatment of tumors
US20060142853A1 (en) 2003-04-08 2006-06-29 Xingwu Wang Coated substrate assembly
GB0308731D0 (en) 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
EP2060274B1 (en) 2003-04-30 2014-03-26 Ramot at Tel-Aviv University Ltd. Method and device for radiotherapy
US7922646B2 (en) 2003-08-20 2011-04-12 International Brachytherapy, S.A. Plastic brachytherapy sources
US20050159809A1 (en) 2004-01-21 2005-07-21 Medtronic Vascular, Inc. Implantable medical devices for treating or preventing restenosis
WO2006003123A2 (en) 2004-06-25 2006-01-12 The European Community, Represented By The European Commission Radionuclides for medical use
US20060014938A1 (en) 2004-07-14 2006-01-19 Groman Ernest V Stable aqueous colloidal lanthanide oxides
DE602005020642D1 (en) 2004-08-13 2010-05-27 Setagon Inc METHOD OF MANUFACTURING MEDICINE PRODUCTS WITH NANOPOROUS LAYERS
GB0423565D0 (en) 2004-10-22 2004-11-24 Algeta As Formulation
WO2006110889A2 (en) 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior University Multi-layer structure having a predetermined layer pattern including an agent
CA2615589A1 (en) * 2005-07-26 2007-02-01 Ramot At Tel Aviv University Ltd. A radioactive surface source and a method for producing the same
US7862496B2 (en) 2005-11-10 2011-01-04 Cianna Medical, Inc. Brachytherapy apparatus and methods for using them
US20080249398A1 (en) 2007-04-09 2008-10-09 Harder George Fred Hybrid Source Containing Multi-Radionuclides for Use in Radiation Therapy
US20100015042A1 (en) 2008-07-03 2010-01-21 Ramot At Tel Aviv University Ltd. Combine radiation therapy and chemotherapy for treating cancer
US8821364B2 (en) * 2008-09-02 2014-09-02 Battelle Memorial Institute Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue
US8764619B2 (en) 2009-04-21 2014-07-01 Breast Microseed Llc Brachytherapy fiducial needle fixation system and method
WO2011018792A1 (en) 2009-08-12 2011-02-17 Soreq NRC Brachytherapy radioactive seeds compositions and methods for producing them
WO2012066498A1 (en) 2010-11-18 2012-05-24 Northern Oncology (Pty) Ltd Brachytherapy seed, methodology and calculating dose of brachytherapy and method of treatment
CN103596622A (en) 2011-06-01 2014-02-19 核通运营有限公司 Brachytherapy source assembly
US20140296612A1 (en) 2013-03-26 2014-10-02 David Schwartz Brachytherapy Assist Device
US9951399B2 (en) 2014-04-09 2018-04-24 Los Alamos National Security, Llc Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target
US9433690B1 (en) 2015-02-26 2016-09-06 Sciencons AS Radiopharmaceutical solutions with advantageous properties
MX2017016217A (en) 2015-06-18 2018-04-24 Acuitybio Corp Implantable drug delivery compositions and methods of use thereof.
RU2606108C2 (en) * 2015-11-02 2017-01-10 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) Method of brachytherapy for localised prostate cancer
JP2021519126A (en) * 2018-04-02 2021-08-10 アルファ タウ メディカル リミテッド Controlled release of radionuclides

Also Published As

Publication number Publication date
JP7232489B2 (en) 2023-03-03
AU2018265386A1 (en) 2019-10-31
US11529432B2 (en) 2022-12-20
AU2018265386B2 (en) 2020-07-23
RU2019139620A (en) 2021-06-11
US20230014526A1 (en) 2023-01-19
KR102560243B1 (en) 2023-07-27
CA3059534A1 (en) 2018-11-15
WO2018207105A1 (en) 2018-11-15
US20210154340A1 (en) 2021-05-27
JP2020519322A (en) 2020-07-02
EP3621692A1 (en) 2020-03-18
KR20200007816A (en) 2020-01-22
MX2019013346A (en) 2020-01-20
JP2023055923A (en) 2023-04-18
RU2763750C2 (en) 2022-01-10
CN110603076A (en) 2019-12-20
RU2019139620A3 (en) 2021-07-01
EP3621692A4 (en) 2021-01-13
ZA201906581B (en) 2021-01-27

Similar Documents

Publication Publication Date Title
SG11201910176PA (en) Polymer coatings for brachytherapy devices
SG11201909949XA (en) Targeted immunotolerance
SG11201909168VA (en) Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor
SG11201900480YA (en) Anti-tim-3 antibodies
SG11201805186VA (en) Compositions and methods for immune cell modulation in adoptive immunotherapies
SG11201806624XA (en) Deposition of molybdenum thin films using a molybdenum carbonyl precursor
SG11201903857UA (en) Antibodies to pd-1 and uses thereof
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201811564QA (en) Methods of treating ovarian cancer
SG11201808125RA (en) Methods for solid tumor treatment
SG11201805311XA (en) Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
SG11201811095UA (en) Multi-level storage in ferroelectric memory
SG11201907673YA (en) Pharmaceutical compositions for combination therapy
SG11201805828YA (en) Method of treating c3 glomerulopathy
SG11201803834UA (en) Methods for treating conditions associated with masp-2 dependent complement activation
SG11201806825RA (en) A data source system agnostic fact category partitioned information repository and methods for the insertion and retrieval of data using the information repository
SG11201408810TA (en) Methods of treating arthritis
SG11201910195WA (en) Methods for trapping and barcoding discrete biological units in hydrogel
SG11201808106YA (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
SG11201909064RA (en) Combination of an anti-pd-l1 antibody and a dna-pk inhibitor for the treatment of cancer
SG11201808686VA (en) Synthesis of indazoles
SG11201901228QA (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
SG11201906973TA (en) Multiple transgene recombinant adenovirus
SG11201903786UA (en) Farnesyltransferase inhibitors for use in methods of treating cancer
SG11201906987RA (en) Combination of a ppar agonist with a fxr agonist